We take our role in your health very seriously. Come in today to see how we can help.
The location of Bulloch's offers rich Cedar City history. The original building was built in 1881 and would become the Cedar Sheep Association Store. Here, members of the Sheep Co-Op turned in their sheep and land to the organization and in return, were able to draw from the store what they needed in the currency of supplies, food, and staples.
Another purpose of the store (the basement) was to distribute mutton (meat from a mature sheep) to the association members after processing at the slaughterhouse. Years later, the Co-Op closed, and the sheep and land were divided up among the stockholders.
When the Vickers family took over in 1996, the original Cedar Sheep Association insignia seemed to be a forgotten part of the building, as it had been covered by a canopy. Evan and Chris decided to have the sign uncovered, cleaned and put back on display where it remains visible today.
During the late 90’s, Chris’s father Terry was tasked with opening the wall between the original building and the building to the south to its current configuration. This building is currently the location of the boutique in Bulloch’s.
In 1917, a new building was built to the south of the original store with an archway opening between the two buildings. The upstairs of this building was occupied by doctors and served as the first hospital in Cedar City. The main floor became a store dealing mostly in clothing, dry goods, and other department store merchandise but in 1934 became the first drugstore, Thornton Drug. It was 1955 when it finally transitioned to Bulloch’s Drug.
Read more
Staying informed is also a great way to stay healthy. Keep up-to-date with all the latest health news here.
11 Dec
Researchers look at how 10 common activities affect low back pain over the short and long term.
10 Dec
A landmark study finds Vietnam veterans exposed to Agent Orange face a significantly higher risk of developing myelodysplastic syndrome. Researchers hope this finding helps veterans get the health and disability benefits they’ve been denied for 50 years.
09 Dec
A review of 48 clinical trials on GLP-1 safety suggests the popular meds probably have little to no effect on cancer risk.
Smokers who use cigarettes and vape devices interchangeably might not be doing themselves as much of a disservice as once feared, a new study says.
These "dual users" are more likely to eventually quit smoking than people who smoke without vaping, researchers reported Dec. 10 in the journal Nicotine & Tobacco Research.
D...
Virtual nurses aren’t an effective way to help hospitals deal with a lack of staffing, a new study says.
Hospitals struggling to attract and retain nurses are trying out virtual nursing programs, in which nurses in remote locations rely on video and messaging technologies to keep tabs on patients, researchers said.
But these vi...
The best way to improve amputees’ control over a bionic hand is to give the hand a mind of its own, a new study argues.
A bionic hand that’s controlled by an artificial intelligence (AI) program, but under the direction of the amputee, provides the best approximation of normal hand dexterity, researchers said Dec. 9 in the jour...
People could learn within 15 minutes whether they are infected with hepatitis C, thanks to a rapid test developed by Northwestern University.
The test will allow doctors to diagnose infections during an office visit and kickstart patients’ treatment before they leave, researchers said.
“This test could revolutionize HCV c...
More than half of people with a rare life-threatening bleeding condition received lasting relief from an experimental antibody treatment, clinical trial results show.
Ianalumab, a monoclonal antibody, helped patients with immune thrombocytopenia (ITP) maintain safe platelet counts without serious bleeding episodes for at least a year, acco...
Less might be more when it comes to immunotherapy treatment of melanoma, a new study says.
Lower doses of a drug used to treat melanoma can provide better results while reducing side effects, researchers reported Dec. 8 in the Journal of the National Cancer Institute.
“The results are highly interesting in oncology, as...